After BCG intravesical treatment on an experimental study of bladder cancer, the authors detected a higher number of CD4 T-cells infiltrating the tumor (TIL) and correlated it with increased IFN-γ by these specific CD4 T cells. This evidence concerns the gene CD4 and urinary bladder carcinoma.